{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T08:47:58Z","timestamp":1791276478343,"version":"4.1.0"},"reference-count":77,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2011,5,1]],"date-time":"2011-05-01T00:00:00Z","timestamp":1304208000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Contemporary Clinical Trials"],"published-print":{"date-parts":[[2011,5]]},"DOI":"10.1016\/j.cct.2011.01.008","type":"journal-article","created":{"date-parts":[[2011,1,24]],"date-time":"2011-01-24T09:04:15Z","timestamp":1295859855000},"page":"437-445","source":"Crossref","is-referenced-by-count":22,"title":["Effect of statin therapy on disease progression in pediatric ADPKD: Design and baseline characteristics of participants"],"prefix":"10.1016","volume":"32","clinical-trial-number":[{"clinical-trial-number":"nct00456365","registry":"10.18810\/clinical-trials-gov"}],"author":[{"given":"Melissa A.","family":"Cadnapaphornchai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diana M.","family":"George","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amirali","family":"Masoumi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kim","family":"McFann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John D.","family":"Strain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert W.","family":"Schrier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cct.2011.01.008_bb0005","series-title":"Diseases of the kidney and urinary tract","first-page":"502","article-title":"Polycystic kidney disease","author":"Ecder","year":"2007"},{"issue":"10","key":"10.1016\/j.cct.2011.01.008_bb0010","doi-asserted-by":"crossref","first-page":"2528","DOI":"10.1097\/01.ASN.0000141055.57643.E0","article-title":"Intraflagellar transport and cilia-dependent renal disease: the ciliary hypothesis of polycystic kidney disease","volume":"15","author":"Pazour","year":"2004","journal-title":"J Am Soc Nephrol"},{"issue":"10","key":"10.1016\/j.cct.2011.01.008_bb0015","doi-asserted-by":"crossref","first-page":"2508","DOI":"10.1097\/01.ASN.0000029587.47950.25","article-title":"The polycystic kidney disease proteins, polycystin-1, polycystin-2, polaris, and cystin, are co-localized in renal cilia","volume":"13","author":"Yoder","year":"2002","journal-title":"J Am Soc Nephrol"},{"issue":"2","key":"10.1016\/j.cct.2011.01.008_bb0020","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1038\/ng1076","article-title":"Polycystins 1 and 2 mediate mechanosensation in the primary cilium of kidney cells","volume":"33","author":"Nauli","year":"2003","journal-title":"Nat Genet"},{"issue":"3","key":"10.1016\/j.cct.2011.01.008_bb0025","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1007\/s00232-002-1055-z","article-title":"Bending the primary cilium opens Ca2+-sensitive intermediate-conductance K+ channels in MDCK cells","volume":"191","author":"Praetorius","year":"2003","journal-title":"J Membr Biol"},{"issue":"1","key":"10.1016\/j.cct.2011.01.008_bb0030","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1038\/ncpneph0070","article-title":"Mechanisms of disease: autosomal dominant and recessive polycystic kidney diseases","volume":"2","author":"Torres","year":"2006","journal-title":"Nat Clin Pract Nephrol"},{"issue":"1","key":"10.1016\/j.cct.2011.01.008_bb0035","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1681\/ASN.V121194","article-title":"Hypertension in autosomal-dominant polycystic kidney disease: early occurrence and unique aspects","volume":"12","author":"Ecder","year":"2001","journal-title":"J Am Soc Nephrol"},{"issue":"2","key":"10.1016\/j.cct.2011.01.008_bb0040","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1046\/j.1523-1755.2003.00776.x","article-title":"Epidemiological study of kidney survival in autosomal dominant polycystic kidney disease","volume":"63","author":"Schrier","year":"2003","journal-title":"Kidney Int"},{"key":"10.1016\/j.cct.2011.01.008_bb0045","doi-asserted-by":"crossref","first-page":"2048","DOI":"10.1681\/ASN.V5122048","article-title":"Causes of death in autosomal dominant polycystic kidney disease","volume":"5","author":"Fick","year":"1995","journal-title":"J Am Soc Nephrol"},{"issue":"9","key":"10.1016\/j.cct.2011.01.008_bb0050","doi-asserted-by":"crossref","first-page":"1888","DOI":"10.1681\/ASN.2008080882","article-title":"Renal volume, renin\u2013angiotensin\u2013aldosterone system, hypertension, and left ventricular hypertrophy in patients with autosomal dominant polycystic kidney disease","volume":"20","author":"Schrier","year":"2009","journal-title":"J Am Soc Nephrol"},{"issue":"6 Pt 2","key":"10.1016\/j.cct.2011.01.008_bb0055","doi-asserted-by":"crossref","first-page":"55S","DOI":"10.1016\/S0895-7061(01)02070-2","article-title":"Modulating angiotensin II-induced inflammation by HMG Co-A reductase inhibition","volume":"14","author":"Dechend","year":"2001","journal-title":"Am J Hypertens"},{"issue":"16","key":"10.1016\/j.cct.2011.01.008_bb0060","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1056\/NEJM199010183231602","article-title":"The renin\u2013angiotensin aldosterone system and autosomal dominant polycystic kidney disease","volume":"323","author":"Chapman","year":"1990","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1016\/j.cct.2011.01.008_bb0065","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1038\/ki.1994.374","article-title":"Differences in hormonal and renal vascular responses between normotensive patients with autosomal dominant polycystic kidney disease and unaffected family members","volume":"46","author":"Barrett","year":"1994","journal-title":"Kidney Int"},{"issue":"3","key":"10.1016\/j.cct.2011.01.008_bb0070","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1038\/ki.1991.238","article-title":"Renal, cardiovascular and hormonal characteristics of young adults with autosomal dominant polycystic kidney disease","volume":"40","author":"Harrap","year":"1991","journal-title":"Kidney Int"},{"issue":"5","key":"10.1016\/j.cct.2011.01.008_bb0075","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1038\/ki.1988.233","article-title":"Hypertension in autosomal dominant polycystic kidney disease","volume":"34","author":"Bell","year":"1988","journal-title":"Kidney Int"},{"key":"10.1016\/j.cct.2011.01.008_bb0080","doi-asserted-by":"crossref","first-page":"3C","DOI":"10.1016\/S0002-9149(01)01538-7","article-title":"Experimental and clinical evidence that angiotensin II is an independent risk factor for cardiovascular disease","volume":"87","author":"Brunner","year":"2001","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.cct.2011.01.008_bb0085","doi-asserted-by":"crossref","first-page":"22D","DOI":"10.1016\/0002-9149(90)90473-E","article-title":"Potential role of the tissue renin\u2013angiotensin system in the pathophysiology of congestive heart failure","volume":"66","author":"Hirsch","year":"1990","journal-title":"Am J Cardiol"},{"issue":"Suppl 1","key":"10.1016\/j.cct.2011.01.008_bb0090","doi-asserted-by":"crossref","first-page":"S42","DOI":"10.1093\/ndt\/14.suppl_1.42","article-title":"Angiotensin II: a pivotal factor in the progression of renal diseases","volume":"14","author":"Wolf","year":"1999","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.cct.2011.01.008_bb0095","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1161\/01.CIR.95.3.588","article-title":"Role of superoxide in angiotensin II-induced but not catecholamine-induced hypertension","volume":"95","author":"Laursen","year":"1997","journal-title":"Circulation"},{"key":"10.1016\/j.cct.2011.01.008_bb0100","doi-asserted-by":"crossref","first-page":"23317","DOI":"10.1074\/jbc.271.38.23317","article-title":"P22phox is a critical component of the superoxide-generating NADH\/NADPH system and regulates angiotensin II-induced hypertrophy in vascular smooth muscle cells","volume":"271","author":"Ushio-Fukai","year":"1996","journal-title":"J Biol Chem"},{"key":"10.1016\/j.cct.2011.01.008_bb0105","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1161\/01.HYP.29.1.366","article-title":"Angiotensin II signaling in vascular smooth muscle: new concepts","volume":"29","author":"Griendling","year":"1997","journal-title":"Hypertension"},{"key":"10.1016\/j.cct.2011.01.008_bb0110","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1038\/ki.1997.385","article-title":"Selective antagonism of the AT1 receptor inhibits angiotensin II stimulated DNA and protein synthesis in primary cultures of human proximal tubular cells","volume":"3","author":"Chatterjee","year":"1997","journal-title":"Kidney Int"},{"key":"10.1016\/j.cct.2011.01.008_bb0115","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1038\/ki.1997.480","article-title":"Angiotensin II modulates cell growth-related events and synthesis of matrix proteins in renal interstitial fibroblasts","volume":"6","author":"Ruiz-Ortega","year":"1997","journal-title":"Kidney Int"},{"key":"10.1016\/j.cct.2011.01.008_bb0120","first-page":"92","article-title":"Epithelial hyperplasia in human polycystic kidney diseases. Its role in pathogenesis and risk of neoplasia","volume":"1","author":"Bernstein","year":"1987","journal-title":"Am J Pathol"},{"key":"10.1016\/j.cct.2011.01.008_bb0125","first-page":"S93","article-title":"Mechanisms of progression in autosomal dominant polycystic kidney disease","volume":"63","author":"Grantham","year":"1997","journal-title":"Kidney Int Suppl"},{"issue":"4","key":"10.1016\/j.cct.2011.01.008_bb0130","doi-asserted-by":"crossref","first-page":"820","DOI":"10.2215\/CJN.02810608","article-title":"Prospective change in renal volume and function in children with ADPKD","volume":"4","author":"Cadnapaphornchai","year":"2009","journal-title":"Clin J Am Soc Nephrol"},{"issue":"6","key":"10.1016\/j.cct.2011.01.008_bb0135","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1016\/S0090-4295(96)00314-7","article-title":"Renal hemodynamic effects of lovastatin in a renal ablation model","volume":"48","author":"Hafez","year":"1996","journal-title":"Urology"},{"issue":"5","key":"10.1016\/j.cct.2011.01.008_bb0140","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1016\/S0090-4295(97)00338-5","article-title":"Renal microcirculatory effects of lovastatin in a rat model of reduced renal mass","volume":"50","author":"Glazer","year":"1997","journal-title":"Urology"},{"issue":"4","key":"10.1016\/j.cct.2011.01.008_bb0145","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1097\/00000441-199904000-00001","article-title":"Lovastatin preserves renal function in experimental diabetes","volume":"317","author":"Inman","year":"1999","journal-title":"Am J Med Sci"},{"issue":"1","key":"10.1016\/j.cct.2011.01.008_bb0150","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1006\/jsre.2001.6256","article-title":"Pravastatin, a 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor, attenuates renal injury in an experimental model of ischemia\u2013reperfusion","volume":"101","author":"Joyce","year":"2001","journal-title":"J Surg Res"},{"issue":"3","key":"10.1016\/j.cct.2011.01.008_bb0155","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1053\/ajkd.2003.50140","article-title":"A controlled, prospective study of the effects of atorvastatin on proteinuria and progression of kidney disease","volume":"41","author":"Bianchi","year":"2003","journal-title":"Am J Kidney Dis"},{"issue":"11","key":"10.1016\/j.cct.2011.01.008_bb0160","doi-asserted-by":"crossref","first-page":"2152","DOI":"10.1093\/ndt\/16.11.2152","article-title":"Effect of simvastatin on renal function in autosomal dominant polycystic kidney disease","volume":"16","author":"van Dijk","year":"2001","journal-title":"Nephrol Dial Transplant"},{"issue":"1","key":"10.1016\/j.cct.2011.01.008_bb0165","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/S0022-5347(01)66010-5","article-title":"Lovastatin has direct renal hemodynamic effects in a rodent model","volume":"156","author":"Stowe","year":"1996","journal-title":"J Urol"},{"key":"10.1016\/j.cct.2011.01.008_bb0170","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1210\/jc.87.4.1451","article-title":"Pleiotropic effects of statins: lipid reduction and beyond","volume":"87","author":"McFarlane","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"10.1016\/j.cct.2011.01.008_bb0175","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1046\/j.1523-1755.2000.00304.x","article-title":"Cerivastatin prevents angiotensin II-induced renal injury independent of blood pressure- and cholesterol-lowering effects","volume":"58","author":"Park","year":"2000","journal-title":"Kidney Int"},{"key":"10.1016\/j.cct.2011.01.008_bb0180","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/0272-6386(95)90497-2","article-title":"Effect of lovastatin on the development of polycystic kidney disease in the Han:SPRD rat","volume":"26","author":"Gile","year":"1995","journal-title":"Am J Kidney Dis"},{"issue":"3","key":"10.1016\/j.cct.2011.01.008_bb0185","doi-asserted-by":"crossref","first-page":"F854","DOI":"10.1152\/ajprenal.00059.2007","article-title":"Effect of statin and angiotensin-converting enzyme inhibition on structural and hemodynamic alterations in autosomal dominant polycystic kidney disease model","volume":"293","author":"Zafar","year":"2007","journal-title":"Am J Physiol Ren Physiol"},{"issue":"3","key":"10.1016\/j.cct.2011.01.008_bb0190","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1038\/ki.1983.51","article-title":"Rate of functional deterioration in polycystic kidney disease","volume":"23","author":"Franz","year":"1983","journal-title":"Kidney Int"},{"issue":"6","key":"10.1016\/j.cct.2011.01.008_bb0195","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1038\/ki.1990.330","article-title":"Renal structure and hypertension in autosomal dominant polycystic kidney disease","volume":"38","author":"Gabow","year":"1990","journal-title":"Kidney Int"},{"issue":"5","key":"10.1016\/j.cct.2011.01.008_bb0200","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1038\/ki.1992.195","article-title":"Factors affecting the progression of renal disease in autosomal-dominant polycystic kidney disease","volume":"41","author":"Gabow","year":"1992","journal-title":"Kidney Int"},{"issue":"9","key":"10.1016\/j.cct.2011.01.008_bb0205","doi-asserted-by":"crossref","first-page":"1654","DOI":"10.1681\/ASN.V491654","article-title":"The spectrum of autosomal dominant polycystic kidney disease in children","volume":"4","author":"Fick","year":"1994","journal-title":"J Am Soc Nephrol"},{"issue":"2","key":"10.1016\/j.cct.2011.01.008_bb0210","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/S0272-6386(12)80541-5","article-title":"Clinical profiles of gross hematuria in autosomal dominant polycystic kidney disease","volume":"20","author":"Gabow","year":"1992","journal-title":"Am J Kidney Dis"},{"issue":"2","key":"10.1016\/j.cct.2011.01.008_bb0215","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1038\/ki.1989.38","article-title":"The clinical utility of renal concentrating capacity in polycystic kidney disease","volume":"35","author":"Gabow","year":"1989","journal-title":"Kidney Int"},{"issue":"6","key":"10.1016\/j.cct.2011.01.008_bb0220","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1681\/ASN.V561349","article-title":"Overt proteinuria and microalbuminuria in autosomal-dominant polycystic kidney disease","volume":"5","author":"Chapman","year":"1994","journal-title":"J Am Soc Nephrol"},{"issue":"6","key":"10.1016\/j.cct.2011.01.008_bb0225","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1053\/ajkd.2002.33379","article-title":"Relationship between renal volume growth and renal function in autosomal dominant polycystic kidney disease: a longitudinal study","volume":"39","author":"Fick-Brosnahan","year":"2002","journal-title":"Am J Kidney Dis"},{"issue":"8","key":"10.1016\/j.cct.2011.01.008_bb0230","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1681\/ASN.V1181505","article-title":"Quantification and longitudinal trends of kidney, renal cyst, and renal parenchyma volumes in autosomal dominant polycystic kidney disease","volume":"11","author":"King","year":"2000","journal-title":"J Am Soc Nephrol"},{"issue":"1","key":"10.1016\/j.cct.2011.01.008_bb0235","doi-asserted-by":"crossref","first-page":"102","DOI":"10.2215\/CJN.04310709","article-title":"The HALT polycystic kidney disease trials: design and implementation","volume":"5","author":"Chapman","year":"2010","journal-title":"Clin J Am Soc Nephrol"},{"issue":"9","key":"10.1016\/j.cct.2011.01.008_bb0240","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1056\/NEJMoa1003491","article-title":"Everolimus in patients with autosomal dominant polycystic kidney disease","volume":"363","author":"Walz","year":"2010","journal-title":"N Engl J Med"},{"issue":"9","key":"10.1016\/j.cct.2011.01.008_bb0245","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1056\/NEJMoa0907419","article-title":"Sirolimus and kidney growth in autosomal dominant polycystic kidney disease","volume":"363","author":"Serra","year":"2010","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1016\/j.cct.2011.01.008_bb0250","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1046\/j.1523-1755.2003.00185.x","article-title":"Renal structure in early autosomal-dominant polycystic kidney disease (ADPKD): The Consortium for Radiologic Imaging Studies of Polycystic Kidney Disease (CRISP) cohort","volume":"64","author":"Chapman","year":"2003","journal-title":"Kidney Int"},{"issue":"6","key":"10.1016\/j.cct.2011.01.008_bb0255","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1016\/S0272-6386(83)80044-4","article-title":"Epidemiology of adult polycystic kidney disease, Olmsted County, Minnesota: 1935\u20131980","volume":"2","author":"Iglesias","year":"1983","journal-title":"Am J Kidney Dis"},{"issue":"5","key":"10.1016\/j.cct.2011.01.008_bb0260","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1038\/ki.1993.355","article-title":"Autosomal dominant polycystic kidney disease in Toronto","volume":"44","author":"Roscoe","year":"1993","journal-title":"Kidney Int"},{"issue":"9147","key":"10.1016\/j.cct.2011.01.008_bb0265","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/S0140-6736(98)03495-3","article-title":"Comparison of phenotypes of polycystic kidney disease types 1 and 2. European PKD1\u2013PKD2 Study Group","volume":"353","author":"Hateboer","year":"1999","journal-title":"Lancet"},{"issue":"8","key":"10.1016\/j.cct.2011.01.008_bb0270","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1681\/ASN.V881292","article-title":"Left ventricular hypertrophy in autosomal dominant polycystic kidney disease","volume":"8","author":"Chapman","year":"1997","journal-title":"J Am Soc Nephrol"},{"issue":"9","key":"10.1016\/j.cct.2011.01.008_bb0275","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1038\/ki.2008.397","article-title":"Increased left ventricular mass in children with autosomal dominant polycystic kidney disease and borderline hypertension","volume":"74","author":"Cadnapaphornchai","year":"2008","journal-title":"Kidney Int"},{"issue":"12","key":"10.1016\/j.cct.2011.01.008_bb0280","doi-asserted-by":"crossref","first-page":"2032","DOI":"10.1681\/ASN.V5122032","article-title":"Cardiovascular abnormalities in children with autosomal dominant polycystic kidney disease","volume":"5","author":"Ivy","year":"1995","journal-title":"J Am Soc Nephrol"},{"issue":"4","key":"10.1016\/j.cct.2011.01.008_bb0285","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1161\/01.CIR.87.4.1328","article-title":"Distribution and functional significance of cardiac angiotensin converting enzyme in hypertrophied rat hearts","volume":"87","author":"Schunkert","year":"1993","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.cct.2011.01.008_bb0290","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1161\/01.CIR.83.1.13","article-title":"Cardiac hypertrophy. Mechanical, neural, and endocrine dependence","volume":"83","author":"Morgan","year":"1991","journal-title":"Circulation"},{"issue":"7","key":"10.1016\/j.cct.2011.01.008_bb0295","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1097\/01.ASN.0000018407.60002.B9","article-title":"Cardiac and renal effects of standard versus rigorous blood pressure control in autosomal-dominant polycystic kidney disease: results of a seven-year prospective randomized study","volume":"13","author":"Schrier","year":"2002","journal-title":"J Am Soc Nephrol"},{"issue":"11","key":"10.1016\/j.cct.2011.01.008_bb0300","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1046\/j.1440-1681.1999.03165.x","article-title":"Simvastatin inhibits cardiac hypertrophy and angiotensin-converting enzyme activity in rats with aortic stenosis","volume":"26","author":"Luo","year":"1999","journal-title":"Clin Exp Pharmacol Physiol"},{"issue":"2","key":"10.1016\/j.cct.2011.01.008_bb0305","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.cct.2005.01.001","article-title":"Design and baseline characteristics of participants in the study of antihypertensive therapy in children and adolescents with autosomal dominant polycystic kidney disease (ADPKD)","volume":"26","author":"Cadnapaphornchai","year":"2005","journal-title":"Contemp Clin Trials"},{"issue":"1","key":"10.1016\/j.cct.2011.01.008_bb0310","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S0002-9149(02)02381-0","article-title":"Comparison of interstudy reproducibility of cardiovascular magnetic resonance with two-dimensional echocardiography in normal subjects and in patients with heart failure or left ventricular hypertrophy","volume":"90","author":"Grothues","year":"2002","journal-title":"Am J Cardiol"},{"issue":"1","key":"10.1016\/j.cct.2011.01.008_bb0315","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/S1010-7940(03)00183-0","article-title":"Assessment of left ventricular mass regression after aortic valve replacement\u2013cardiovascular magnetic resonance versus M-mode echocardiography","volume":"24","author":"Rajappan","year":"2003","journal-title":"Eur J Cardiothorac Surg"},{"issue":"5","key":"10.1016\/j.cct.2011.01.008_bb0320","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1080\/003655998750015331","article-title":"Microalbuminuria in normotensive patients with autosomal-dominant polycystic kidney disease","volume":"32","author":"Martinez-Vea","year":"1998","journal-title":"Scand J Urol Nephrol"},{"key":"10.1016\/j.cct.2011.01.008_bb0325","doi-asserted-by":"crossref","first-page":"1908","DOI":"10.1681\/ASN.V9101908","article-title":"Factors relating to urinary protein excretion in children with autosomal dominant polycystic kidney disease","volume":"9","author":"Sharp","year":"1998","journal-title":"J Am Soc Nephrol"},{"issue":"6","key":"10.1016\/j.cct.2011.01.008_bb0330","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1159\/000046648","article-title":"Effect of cerivastatin on urinary albumin excretion and plasma endothelin-1 concentrations in type 2 diabetes patients with microalbuminuria and dyslipidemia","volume":"21","author":"Nakamura","year":"2001","journal-title":"Am J Nephrol"},{"key":"10.1016\/j.cct.2011.01.008_bb0335","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1542\/peds.58.2.259","article-title":"A simple estimate of glomerular filtration rate in children derived from body length and plasma creatinine","volume":"2","author":"Schwartz","year":"1976","journal-title":"Pediatrics"},{"key":"10.1016\/j.cct.2011.01.008_bb0340","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1146\/annurev.me.19.020168.001435","article-title":"Growth and physiological development during adolescence","volume":"19","author":"Marshall","year":"1968","journal-title":"Annu Rev Med"},{"issue":"235","key":"10.1016\/j.cct.2011.01.008_bb0345","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1136\/adc.44.235.291","article-title":"Variations in pattern of pubertal changes in girls","volume":"44","author":"Marshall","year":"1969","journal-title":"Arch Dis Child"},{"issue":"239","key":"10.1016\/j.cct.2011.01.008_bb0350","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1136\/adc.45.239.13","article-title":"Variations in the pattern of pubertal changes in boys","volume":"45","author":"Marshall","year":"1970","journal-title":"Arch Dis Child"},{"key":"10.1016\/j.cct.2011.01.008_bb0355","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1542\/peds.114.2.S2.555","article-title":"The fourth report on the diagnosis, evaluation, and treatment of high blood pressure in children and adolescents","volume":"114","year":"2004","journal-title":"Pediatrics"},{"issue":"2","key":"10.1016\/j.cct.2011.01.008_bb0360","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/S0212-6567(00)78470-8","article-title":"Evaluation and validation of Omron Hem 705CP and Hem 706\/711 monitors for self-measurement of blood pressure","volume":"25","author":"Artigao","year":"2000","journal-title":"Aten Primaria"},{"issue":"3 March","key":"10.1016\/j.cct.2011.01.008_bb0365","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1136\/bmj.322.7285.531","article-title":"Blood pressure measuring devices: recommendations of the European Society of Hypertension","volume":"322","author":"O'Brien","year":"2001","journal-title":"BMJ"},{"issue":"4","key":"10.1016\/j.cct.2011.01.008_bb0370","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1097\/00004728-200007000-00019","article-title":"Volumetric measurement of renal cysts and parenchyma using MRI: phantoms and patients with polycystic kidney disease","volume":"24","author":"Bae","year":"2000","journal-title":"J Comput Assist Tomogr"},{"issue":"6","key":"10.1016\/j.cct.2011.01.008_bb0375","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1053\/j.ajkd.2005.08.026","article-title":"Sonographic assessment of the severity and progression of autosomal dominant polycystic kidney disease: the Consortium of Renal Imaging Studies in Polycystic Kidney Disease (CRISP)","volume":"46","author":"O'Neill","year":"2005","journal-title":"Am J Kidney Dis"},{"issue":"1","key":"10.1016\/j.cct.2011.01.008_bb0380","doi-asserted-by":"crossref","first-page":"112","DOI":"10.2215\/CJN.00910306","article-title":"Magnetic resonance measurements of renal blood flow and disease progression in autosomal dominant polycystic kidney disease","volume":"2","author":"Torres","year":"2007","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.cct.2011.01.008_bb0385","doi-asserted-by":"crossref","unstructured":"Cadnapaphornchai MA, Masoumi A, Strain JD, McFann K, Schrier RW. Magnetic resonance imaging of kidney and cyst volume in children with ADPKD. Clin J Am Soc Nephrol. 2010 Nov 29.","DOI":"10.2215\/CJN.03780410"}],"container-title":["Contemporary Clinical Trials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1551714411000103?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1551714411000103?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,6,4]],"date-time":"2023-06-04T23:33:36Z","timestamp":1685921616000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1551714411000103"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,5]]},"references-count":77,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2011,5]]}},"alternative-id":["S1551714411000103"],"URL":"https:\/\/doi.org\/10.1016\/j.cct.2011.01.008","relation":{},"ISSN":["1551-7144"],"issn-type":[{"value":"1551-7144","type":"print"}],"subject":[],"published":{"date-parts":[[2011,5]]}}}